Originally posted by Glyco
Originally posted by more4less
When you compare GMV to other's in the Health Care Equipment & Services section on the ASX, like Rap and Pck, GMV is the standout one.
G Medical Innovation:
Way ahead of the others to market with product
Proven management in this field.
Already achieved CE, TGA and FDA approval. CFDA very close to being achieved
Management has 100% success in achieving approvals
Actual product that is being sold to the market and used by consumer .
Diversity with recurring revenue from different products
Current revenue from IDTF
Future dual listing for HK and Nasdaq.
2 Factories purpose built and up and running.
Product closed to being launched in China
Backed by experience team of 50 employees world wide and high percentage have worked with Yacov before
cheers m4l
Dow Jones is up by 330 point.
Trade talk
CNBC says China is prepared to increase imports for next 6 years till 2024 to eliminate America US$323 Billion trade deficit.
Market is happy, so up he goes 330 points.
Next few weeks we are likely to see comapny-making news which
@Galilee13 alluded.
Lets catch some of Dows tailwinds.
Cheers.
aimo
China is GMV future and the Prizma is the vehicle Yacov will start with, to help the population and use the technology that will eventually render doctor's office visits obsolete in China.
China is no longer the factory of the world, they are the biggest consumer in the world and any med tech start up wants their product sold in China.
GMV have already booked their space at 2019 CIIE for later in the year. Their stand last year (November) had lot of interest and IMO once approval comes through for CFDA, some of that interest will turn into paid orders .
Prizma is geared up to add new functions on future models and with that comes new interest, new customers and more revenue, plus the recurrring revenue that goes with the purchase.
